Cevec launches ELEVECTA platform
Cevec Pharmaceuticals GmbH has launched a new, scalable production platform for AAV gene therapy vectors.
Author Archive for: TG
About Thomas Gabrielczyk
This author has not written his bio yet.
But we are proud to say that Thomas Gabrielczyk contributed 1118 entries already.
Entries by Thomas Gabrielczyk
Artes enters COVID-19 vaccine race
/in News/by Thomas GabrielczykGerman vaccine developer ARTES Biotechnology GmbH will develop a COVID-19 subunit vaccine based on virus-like particles (VLP), which include two proteins of SARS-CoV-2.
Bayer, Novartis, and Trump convicted by Nature
/in News/by Thomas GabrielczykThe politically overhyped use of old malaria drugs in combination with COVID-19-specific candidates has been demonstrated to be dangerous, reports Nature Medicine.
Drug from worms dampens autoimmune response
/in News/by Thomas GabrielczykGerman researchers have isolated a substance from parasitic roundworm larvae to alleviate inflammation and treat asthma in a rodent model.
COVID-19: Novartis starts study on hyped malaria drug
/in News/by Thomas GabrielczykUp to today, Novartis and Bayer announced donations of several millions of old antimalaria pills based on anecdotical reports of efficacy in COVID-19 patients. Now Novartis has started a study.
COVID 19: Halix ready for vaccine production
/in News/by Thomas GabrielczykDutch Halix BV will manufacture a ChAdOx1 nCoV-19 vaccine, developed at the University of Oxford .
Carbios SAS publishes PET recycling technology
/in News/by Thomas GabrielczykFor years, French Carbios SAS has worked to set up a process that effectively depolymerizes PET, one of the most common plastics. Now its process has been published.
Mobidiags COVID-19 test okayed for emergency use
/in News/by Thomas GabrielczykMolecular diagnostics specialist Mobidiag Ltd has got emergency approval for its Amplidiag® COVID-19 molecular diagnostic test in Finland.
Researchers reconstruct SARS-CoV-2 evolution
/in News/by Thomas GabrielczykBritish researchers have tabled a phylogenetic tree showing different subtypes of SARS-CoV-2 developed in Asia, Europe and the US.
COVID-19: Solnatide approved for compassionate use
/in News/by Thomas GabrielczykAustrian COVID-19 patients with severe lung dysfunction for the first time have a treatment option within a compassionate use program for Apeptico’s solnatide.